Novo Holdings Spruce Biosciences, Inc. Transaction History

Novo Holdings

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$1.15 - $3.17 $2.54 Million - $7 Million	2,208,000 Added 48.91%	6,722,336 $14.9 Million
Q2 2021 Aug 16, 2021	SELL	$10.12 - $17.46 $4.81 Million - $8.29 Million	-475,000 Reduced 9.52%	4,514,336 $50.6 Million
Q4 2020 Feb 16, 2021	BUY	$15.38 - $32.42 $76.7 Million - $162 Million	4,989,336 New	4,989,336 $121 Million

15.4M

16.7K

1.1K

Ticker SPRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,560,200
Market Cap $11.5M
Description
Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from congenital adrenal hyperplasia (CAH), which i...

Get notified when there are updates to the investment portfolio of Novo Holdings, based on Form 13F filings with the SEC.

Stay updated on Novo Holdings with notifications on news.